Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Aprotinin and Sodium Chloride Injection

Approval Number

国药准字H20030385

Company酒泉大得利制药股份有限公司

Registration Date

May 25, 2022

Previous Approval Numbers

国药准字H20030385

Drug Information

Generic Name

抑肽酶氯化钠注射液

Dosage Form

注射剂

Strength

200ml：1112单位抑肽酶与1.8g氯化钠

Drug Type

化学药品

Registration Date

May 25, 2022

Company Information

Applicant Company

Company Name酒泉大得利制药股份有限公司

Company Address

酒泉市高新技术工业园区大得利路6号

Manufacturing Company

Company Name酒泉大得利制药股份有限公司

Company Address

酒泉市高新技术工业园区大得利路6号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy